Coronary restenosis is a medical phenomenon marked by the re-narrowing or blockage of coronary arteries subsequent to an initial medical intervention like angioplasty or the placement of a stent to address coronary artery disease. While these interventions initially succeed in restoring blood flow to the heart, the recurrence of symptoms, such as chest pain or angina, indicates the onset of restenosis. This condition is primarily attributed to the re-growth of tissue within the treated artery, referred to as neointimal hyperplasia, or the reappearance of atherosclerotic plaque. The development of coronary restenosis involves a complex interplay of factors, including patient-specific characteristics, procedural techniques employed during the initial intervention, and the types of devices used. Continuous efforts by researchers and clinicians are focused on devising strategies to mitigate the risk of restenosis. One such advancement includes the development of drug-eluting stents that release medication, aiming to inhibit excessive tissue growth in the treated arteries.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation